This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Frontiers in Cardiovascular Medicine
JANUARY 28, 2025
Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.
95 
Open Heart
MARCH 25, 2025
Background The COVID-19 pandemic necessitated major reallocation of healthcare services. We compared procedure characteristics and outcomes between each pandemic period and the prepandemic period.
81 
HCPLive
APRIL 1, 2024
New data show COPD and IPF, among other interstitial lung diseases, are more significantly associated with poor 30-day outcomes from COVID-19 than asthma.
122 
Heart BMJ
APRIL 15, 2024
Objective To study the association between COVID-19 vaccination and the risk of post-COVID-19 cardiac and thromboembolic complications. Each stage included all individuals eligible for vaccination, with no previous SARS-CoV-2 infection or COVID-19 vaccine at the start date. to 0.29), 0.53 (0.44
98 
NEJM Journal Watch - Cardiology
SEPTEMBER 17, 2024
Patients with post–COVID-19 mRNA vaccination myocarditis had better clinical outcomes at 18 months than those with myocarditis of other etiologies.
75 
HCPLive
MAY 8, 2024
An IMID diagnosis or use of immunomodulatory medications were not shown to be a significant risk factor of severe COVID-19 outcomes.
59 
Med Page Today
APRIL 24, 2024
(MedPage Today) -- Only myocarditis/pericarditis and seizures occurred at higher rates in adolescents and children vaccinated for COVID-19 when compared with historical rates of those outcomes, according to an analysis of safety data from the FDA.
144 
Journal of Clinical Investigation - Cardiology
MARCH 15, 2024
In the relentless battle against the COVID-19 pandemic, the deployment of mRNA vaccines has stood out as a beacon of hope. introduces an approach to potentially enhancing the immune responses generated by COVID-19 mRNA vaccines. The study published in this issue of JCI by Fazli et al.
78 
Heart BMJ
FEBRUARY 26, 2025
The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. Rates of SAVR declined during COVID-19 for all groups, but TAVI rates increased steadily. Results Of 179 645 procedures, there were 139 990 SAVR (mean age 71±10.8
52 
HCPLive
MAY 24, 2024
Age, chronic comorbidities, and COVID-19 vaccination status in patients with IMIDs serve as risk factors for severe COVID-19 outcomes.
52 
HCPLive
DECEMBER 4, 2024
Dexamethasone treatment was linked to worse clinical outcomes in patients with sickle cell disease hospitalized for COVID-19.
59 
Coronary Artery Disease Journal
OCTOBER 23, 2023
Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.
52 
Open Heart
FEBRUARY 17, 2025
We aimed to quantify the impact of health system disruptions during the COVID-19 pandemic, on their clinical outcomes and whether these differed by socioeconomic and ethnic subgroups. Outcomes did not vary by pandemic birth era according to social characteristics.
HCPLive
APRIL 29, 2024
Findings indicated treatment with colchicine resulted in a significant reduction in mortality rate compared with placebo or standard care.
69 
Coronary Artery Disease Journal
OCTOBER 31, 2023
Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Patients with COVID-19 versus those without had significantly greater in-hospital mortality (45.2% reduction in admissions in 2020. In 2020, 3.0%
52 
Open Heart
APRIL 20, 2022
Objective To assess the feasibility, efficacy and safety of performing exercise stress echocardiography (ESE) for the assessment of myocardial ischaemia during the COVID-19 pandemic. Retrospective analysis was performed on follow-up data for outcomes. SE service performance increased to 96.8%
52 
Open Heart
MAY 9, 2022
Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.
52 
Journal of the American Heart Association
JANUARY 31, 2024
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
40 
Stroke Journal
DECEMBER 21, 2023
BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. versus 85.6%;P<0.001),
40 
Stroke Journal
FEBRUARY 1, 2024
Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed.
40 Stroke Journal
JANUARY 30, 2025
Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States. Adults (18) with AIS were compared based on admission date: Pre-COVID period (1/1/2019 12/31/2019) vs. COVID period (3/1/2020 3/1/2021).
40 
Circulation
NOVEMBER 11, 2024
Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel.
40 
Open Heart
MARCH 13, 2024
Importance Although cardiac injury is a known complication of COVID-19 infection, there is no established tool to predict cardiac involvement and in-hospital mortality in this patient population. Main outcomes and measures In-hospital mortality. to 15.03, p=0.101).
52 
Open Heart
AUGUST 30, 2024
Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. OpenSAFELY can be used to continuously monitor changes in national quality-of-care schemes to identify changes in key clinical subgroups early and support prioritisation of recovery from care disrupted by COVID-19.
52 
Stroke Journal
FEBRUARY 1, 2024
Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. but there were fewer women in the COVID-CVST group (50% vs 68%,P<0.01).
40 
European Journal of Cardiovascular Nursing
JANUARY 21, 2025
Abstract Aims The COVID-19 pandemic disrupted healthcare systems and possibly impacted the management of heart failure (HF). This study examined the impact of the pandemic on HF hospitalization activities, outcomes, and costs in Victoria, Australia. Further studies using other data (i.e.
40 
CardioBrief
AUGUST 24, 2020
We still don’t know what COVID-19 is doing to the heart or how we should be investigating it and treating it. Last month JAMA Cardiology published a German cohort study of 100 patients recently recovered from COVID-19… A number of striking problems with the study were noted on Twitter…. Click here to continue reading.
40 
JAMA Cardiology
OCTOBER 31, 2020
This cohort study evaluates the presence of myocardial injury in unselected patients recently recovered from coronavirus disease 2019 (COVID-19).
40 
Journal of Cardiovascular Electrophysiology
JANUARY 7, 2024
Abstract New-onset atrial fibrillation (NOAF) in COVID-19 raises significant clinical and public health issues. This systematic review and meta-analysis aims to compile and analyze the current literature on NOAF in COVID-19 and give a more comprehensive understanding of the prevalence and outcomes of NOAF in COVID-19.
40 HeartRhythm
FEBRUARY 26, 2024
During the COVID-19 pandemic, professional societies recommended deferral of elective procedures for optimal resource utilization.
40 
Open Heart
MARCH 16, 2023
Background The COVID-19 pandemic accelerated the uptake of digital health interventions for the delivery of cardiac rehabilitation (CR). Methods We examined the impact of an evidence-based, digital CR programme on medical, lifestyle and psychosocial outcomes. However, there is a need to evaluate these interventions.
52 
Circulation
NOVEMBER 11, 2024
Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.
40 
HCPLive
APRIL 7, 2025
This review highlights disparities among patients of color in terms of atopic dermatitis prevalence, management, and outcomes in the post-COVID-19 world.
59 
Circulation
JANUARY 22, 2024
The ability to track and report data from these broader aspirational targets will potentially require expansion of existing data sets, development of new data sets, and enhanced integration of technology to collect process and outcome data, as well as partnerships of the AHA with national, state, and local organizations.
Journal of the American Heart Association
FEBRUARY 7, 2024
The primary outcome of the trial was mean change in systolic BP from baseline to end of treatment. A total of 205 participants were enrolled and mean BP fell from 142/87 (systolic BP/diastolic BP) to 131/81 mm Hg (a reduction of 11 (95% CI, 10–12)/7 (95% CI, 6–7) mm Hg,P<0.001).
45 
The American Journal of Cardiology
FEBRUARY 24, 2024
Publication date: Available online 23 February 2024 Source: The American Journal of Cardiology Author(s): Satyam Krishan, Khawaja Hassan Akhtar, Siddharth Agarwal, Jehanzeb Khan, Usman Baber
52 
Stroke Journal
JANUARY 30, 2025
Background:Preceding respiratory tract infections (RTIs) caused by bacteria or viruses are associated with worse stroke outcomes, likely due to an exaggerated inflammatory immune response, endothelial dysfunction, platelet activation, and coagulopathy. aureus(on days 0, 2, and 5) or mouse-adapted SARS-CoV-2 (on day 0). vs. infectedVwf+/+).
40 
Stroke Journal
FEBRUARY 1, 2024
Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (>=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH). 2.51; SAH: 2.76, 1.68-4.54),
40 
Journal of Cardiothoracic Surgery
AUGUST 23, 2024
Enhanced recovery after cardiac surgery (ERACS) protocols have been shown to improve outcomes for electiv. Surgical aortic valve replacement (SAVR) is an established therapy for severe calcific aortic stenosis.
52 
Cardiology Update
AUGUST 4, 2024
The COVID-19 pandemic highlighted the potential of video consults (VCs), even among older patients, to support self-care, improve disease management, and facilitate collaboration with caregivers. Digital consults (DCs) offer a promising solution to enhance GDMT optimization for the growing HF population.
119 
Open Heart
JUNE 24, 2022
Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19 blood pressure endothelium interaction study’, which found that patients with normal blood pressure (BP) at the time of hospital admission with COVID-19 showed an 8.6
DAIC
MAY 15, 2024
These solutions often feature advanced analytics capabilities, empowering clinicians with valuable insights for personalized patient care and outcome improvement. AI algorithms can analyze vast amounts of cardiovascular data to identify patterns, predict outcomes and assist clinicians in making informed decisions.
111 
Open Heart
MAY 9, 2024
The primary outcome was the feasibility of recruiting and randomising 50 patients across two cardiac surgical centres, and secondary outcomes included the feasibility of collecting the planned perioperative data, clinically relevant outcomes and assessments of effective patient identification, screening and recruitment.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content